Frontiers in Immunology (Mar 2022)

MiR-223 as a Regulator and Therapeutic Target in Liver Diseases

  • Jiarong Gu,
  • Hao Xu,
  • Yandong Chen,
  • Na Li,
  • Xin Hou,
  • Xin Hou

DOI
https://doi.org/10.3389/fimmu.2022.860661
Journal volume & issue
Vol. 13

Abstract

Read online

MicroRNAs (miRNAs) are endogenous non-coding single-stranded small molecule RNAs consisting of 20–24 nucleotides that are highly conserved in species evolution. Expression of miRNAs is strictly tissue-specific, and it is chronological in fungi and plants, as well as in animals. MiR-223 has been shown to play a key role in innate immunity, and dysregulation of its expression contributes to the pathogenesis of multiple inflammatory diseases, and cancers. In this article the biosynthesis and functions of miR-223 in innate immunity are reviewed, and the role of miR-223 in liver physiopathology and therapeutic prospects are highlighted.

Keywords